MRNA vs TECH · rev $1.94B vs P/E 65, rev $1.22B
Moderna Inc (MRNA) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
MRNA currently screens at market cap $24.52B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the MRNA and TECH stock pages for the full models.
Not investment advice.